Matches in Wikidata for { <http://www.wikidata.org/entity/Q63838393> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q63838393 description "clinical trial" @default.
- Q63838393 description "ensayu clínicu" @default.
- Q63838393 description "klinisch onderzoek" @default.
- Q63838393 description "клінічне випробування" @default.
- Q63838393 name "Evaluation of Safety and Efficacy of rhNGF in Patients With Stage 2 and 3 Neurotrophic Keratitis." @default.
- Q63838393 type Item @default.
- Q63838393 label "Evaluation of Safety and Efficacy of rhNGF in Patients With Stage 2 and 3 Neurotrophic Keratitis." @default.
- Q63838393 prefLabel "Evaluation of Safety and Efficacy of rhNGF in Patients With Stage 2 and 3 Neurotrophic Keratitis." @default.
- Q63838393 P1050 Q63838393-27A13408-32BB-46F0-A115-C172A3D7FD8F @default.
- Q63838393 P1050 Q63838393-757FE3FF-B4A0-4F69-ABE0-BAD1CCDF0694 @default.
- Q63838393 P1132 Q63838393-0AB79BA4-771E-4A12-A90A-348FCAFEF5F7 @default.
- Q63838393 P1476 Q63838393-E643C090-12AA-4653-BA0F-2B6A255D979C @default.
- Q63838393 P17 Q63838393-3F353076-7059-4CE1-B1C9-17ECA659758C @default.
- Q63838393 P17 Q63838393-4F4487A0-3E94-45FA-878F-071606CDD035 @default.
- Q63838393 P17 Q63838393-A1AAB1E3-8E04-4A33-BE89-D43D40417691 @default.
- Q63838393 P17 Q63838393-AC8082B7-A8EE-4263-B2F2-57471103499D @default.
- Q63838393 P17 Q63838393-B1FA8E00-B2C3-4540-B15E-4BB3F5033DF8 @default.
- Q63838393 P17 Q63838393-C9B0798A-5007-4D08-A245-E12B787CC5EF @default.
- Q63838393 P1813 Q63838393-7F13370C-6AA5-49C9-8B35-37777A1C27B8 @default.
- Q63838393 P2899 Q63838393-C4E6AB74-8991-4059-8EAF-997E3BD23406 @default.
- Q63838393 P3098 Q63838393-D66BD24B-17DC-4CED-AC43-FB1F8B9205B4 @default.
- Q63838393 P31 Q63838393-540B2E59-86B3-47C5-A18D-C67BAD60BE6C @default.
- Q63838393 P580 Q63838393-0F4484C5-4DF8-4014-B81C-3693E5B33044 @default.
- Q63838393 P582 Q63838393-2FE078D3-7D0E-4545-85D3-B32A8F811581 @default.
- Q63838393 P6099 Q63838393-824F2BF4-F151-48D8-AB27-C7D3B52F128B @default.
- Q63838393 P6099 Q63838393-D76C153F-BF46-4834-B613-1056EAAAAE5D @default.
- Q63838393 P6153 Q63838393-967C8638-5069-499B-A84D-FACA4D4D3B2D @default.
- Q63838393 P8363 Q63838393-0664BCFC-9BCE-42CF-B535-743B65744B55 @default.
- Q63838393 P1050 Q1628473 @default.
- Q63838393 P1050 Q757838 @default.
- Q63838393 P1132 "+174" @default.
- Q63838393 P1476 "An 8-week Phase I/II, Multicenter, Randomized, Double-masked, Vehicle Controlled Parallel Group Study With a 48 or 56 Week Follow-up Period to Evaluate the Safety and Efficacy of Two Doses (10 µg/ml and 20 µg/ml) of Recombinant Human Nerve Growth Factor Eye Drops Solution Versus Vehicle in Patients With Stage 2 and 3 of Neurotrophic Keratitis" @default.
- Q63838393 P17 Q142 @default.
- Q63838393 P17 Q145 @default.
- Q63838393 P17 Q183 @default.
- Q63838393 P17 Q29 @default.
- Q63838393 P17 Q36 @default.
- Q63838393 P17 Q38 @default.
- Q63838393 P1813 "REPARO" @default.
- Q63838393 P2899 "+18" @default.
- Q63838393 P3098 "NCT01756456" @default.
- Q63838393 P31 Q30612 @default.
- Q63838393 P580 "2013-01-01T00:00:00Z" @default.
- Q63838393 P582 "2015-04-01T00:00:00Z" @default.
- Q63838393 P6099 Q42824440 @default.
- Q63838393 P6099 Q5452194 @default.
- Q63838393 P6153 Q52899286 @default.
- Q63838393 P8363 Q78089383 @default.